These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20378572)

  • 21. Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria.
    Emadi A; Brodsky RA
    Am J Hematol; 2009 Oct; 84(10):699-701. PubMed ID: 19705437
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab.
    Helley D; de Latour RP; Porcher R; Rodrigues CA; Galy-Fauroux I; Matheron J; Duval A; Schved JF; Fischer AM; Socié G;
    Haematologica; 2010 Apr; 95(4):574-81. PubMed ID: 20081060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successful eculizumab treatment for multiple coronary thrombosis complicated in paroxysmal nocturnal hemoglobinuria].
    Taniguchi A; Ikezoe T; Takeuchi A; Togitani K; Yoshimoto M; Tanioka K; Kitaoka H; Yokoyama A
    Rinsho Ketsueki; 2014 Aug; 55(8):965-9. PubMed ID: 25186487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiphospholipid antibodies in patients with paroxysmal nocturnal haemoglobinuria receiving eculizumab.
    Darnige L; Peffault de Latour R; Zemori L; Socié G; Fischer AM; Helley D;
    Br J Haematol; 2011 Jun; 153(6):789-91. PubMed ID: 21457219
    [No Abstract]   [Full Text] [Related]  

  • 25. Failure of eculizumab to correct paroxysmal cold hemoglobinuria.
    Gregory GP; Opat S; Quach H; Shortt J; Tran H
    Ann Hematol; 2011 Aug; 90(8):989-90. PubMed ID: 21110191
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemolytic anemia after eculizumab in paroxysmal nocturnal hemoglobinuria.
    Berzuini A; Montanelli F; Prati D
    N Engl J Med; 2010 Sep; 363(10):993-4. PubMed ID: 20818912
    [No Abstract]   [Full Text] [Related]  

  • 27. Eculizumab: A novel therapy for paroxysmal nocturnal hemoglobinuria.
    Zareba KM
    Drugs Today (Barc); 2007 Aug; 43(8):539-46. PubMed ID: 17925885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful management of obstructive jaundice due to gallstones with eculizumab in a patient with paroxysmal nocturnal hemoglobinuria.
    Kawano H; Minagawa K; Wakahashi K; Kawano Y; Sada A; Matsui T; Hirano H; Shiomi H; Ku Y; Katayama Y
    Intern Med; 2012; 51(18):2613-6. PubMed ID: 22989836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eculizumab.
    Parker CJ; Kar S; Kirkpatrick P
    Nat Rev Drug Discov; 2007 Jul; 6(7):515-6. PubMed ID: 17715500
    [No Abstract]   [Full Text] [Related]  

  • 30. Eculizumab: a guide to its use in paroxysmal nocturnal hemoglobinuria.
    Keating GM; Lyseng-Williamson KA; McKeage K
    BioDrugs; 2012 Apr; 26(2):125-30. PubMed ID: 22350448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Muus P; Szer J; Hill A; Höchsmann B; Kulasekararaj A; Risitano AM; Van Den Neste E; Liljeholm M; Ebrahim KS; Bedrosian CL; Gao X; Ames D; Socié G
    Am J Hematol; 2016 Mar; 91(3):E16-7. PubMed ID: 26690023
    [No Abstract]   [Full Text] [Related]  

  • 32. [Molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria: a role of NKG2D-medicated immunity].
    Kawaguchi T
    Rinsho Ketsueki; 2010 Aug; 51(8):664-71. PubMed ID: 20805673
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vaccination of patients with paroxysmal nocturnal hemoglobinuria under eculizumab treatment].
    Rodríguez-García J; Fernández-Santos R; García-Erce JA
    Med Clin (Barc); 2012 May; 138(14):640-1. PubMed ID: 22197600
    [No Abstract]   [Full Text] [Related]  

  • 34. Life-threatening desquamating rash and hyperammonemia following administration of eculizumab for paroxysmal nocturnal hemoglobinuria.
    Knoll BM; Letendre L; Steensma DP
    Am J Hematol; 2008 Nov; 83(11):881-3. PubMed ID: 18756538
    [No Abstract]   [Full Text] [Related]  

  • 35. The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab.
    Kelly R; Arnold L; Richards S; Hill A; Bomken C; Hanley J; Loughney A; Beauchamp J; Khursigara G; Rother RP; Chalmers E; Fyfe A; Fitzsimons E; Nakamura R; Gaya A; Risitano AM; Schubert J; Norfolk D; Simpson N; Hillmen P
    Br J Haematol; 2010 May; 149(3):446-50. PubMed ID: 20151973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paroxysmal nocturnal hemoglobinuria--hemolysis before and after eculizumab.
    Risitano AM; Notaro R; Luzzatto L; Hill A; Kelly R; Hillmen P
    N Engl J Med; 2010 Dec; 363(23):2270-2. PubMed ID: 21121856
    [No Abstract]   [Full Text] [Related]  

  • 37. Durable resolution of recurrent microvascular small bowel ischaemia and severe abdominal pain by eculizumab in paroxysmal nocturnal haemoglobinuria.
    Grigg A; Brown M; Szer J
    Intern Med J; 2010 Nov; 40(11):794-5. PubMed ID: 21108715
    [No Abstract]   [Full Text] [Related]  

  • 38. Eculizumab in paroxysmal nocturnal haemoglobinuria.
    Charneski L; Patel PN
    Drugs; 2008; 68(10):1341-6. PubMed ID: 18578555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab.
    Risitano AM; Notaro R; Marando L; Serio B; Ranaldi D; Seneca E; Ricci P; Alfinito F; Camera A; Gianfaldoni G; Amendola A; Boschetti C; Di Bona E; Fratellanza G; Barbano F; Rodeghiero F; Zanella A; Iori AP; Selleri C; Luzzatto L; Rotoli B
    Blood; 2009 Apr; 113(17):4094-100. PubMed ID: 19179465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Elebute M; Kelly R; Urbano-Ispizua A; Hill A; Rother RP; Khursigara G; Fu CL; Omine M; Browne P; Rosse W
    Am J Hematol; 2010 Aug; 85(8):553-9. PubMed ID: 20658586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.